SharmilanThanendrarajanMD

PubMed

• 54 citations
  Clinical value of molecular subtyping multiple myeloma using gene expression profiling.
  Niels Weinhold, Christoph Heuck, Adam Z. Rosenthal, Sharmilan Thanendrarajan, Caleb K. Stein
  Leukemia. 2016-02-01
• 20 citations
  Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
  Shayu Deshpande, Ruslana Tytarenko, Yan Wang, Eileen M Boyle, Cody Ashby
  European Journal of Haematology. 2021-02-01
• 255 citations
  Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
  Leo Rasche, Shweta S. Chavan, Owen W. Stephens, Purvi Patel, Ruslana Tytarenko
  Nature Communications. 2017-08-16

Journal Articles

• Mesenchymal Stem Cells Gene Signature in High‐Risk Myeloma Bone Marrow Linked to Suppression of Distinct IGFBP2‐Expressing Small Adipocytes  
  Bart Barlogie, Sharmilan Thanendrarajan, Carolina Schinke, British Journal of Haematology

Abstracts/Posters

• The Role of PHF19 As a Promoter of Tumorigenicity and Therapeutic Target in Multiple Myeloma
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Translational Switch of MYC Protein Aliases in Myeloma Tumor Cells
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Translational Switch of MYC Protein Aliases in Myeloma Tumor Cells
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Analysis of the Sub-Clonal Structure of Smoldering Myeloma over Time Provides a New Means of Disease Monitoring and Highlights Evolutionary Trajectories Leading to Mye...
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Proliferation and Molecular Risk Score of Low Risk Myeloma Cells Are Increased in High Risk Microenvironment Via Augmented Bioavailability of Growth Factors 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long-Term Follow-up Identifies Double Hit and Key Mutations As Impacting Progression Free and Overall Survival in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Extracting Prognostic Molecular Information from PET-CT Imaging of Multiple Myeloma Using Radiomic Approaches 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Mutational Landscape of Primary Plasma Cell Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all